CD4 and neoplasm: The presence of CD8+ T cells expressing inhibitory markers such as LAG3, TIGIT, KLRC1, and PD-1, and FOXP3+ regulatory CD4+ T cells may prevent effective T cell–mediated tumor control in PDAC.